GRADE guidelines 6. Rating the quality of evidence-imprecision

被引:1611
作者
Guyatt, Gordon H. [1 ,2 ]
Oxman, Andrew D. [3 ]
Kunz, Regina [4 ,5 ]
Brozek, Jan [1 ]
Alonso-Coello, Pablo [6 ,7 ]
Ring, David [8 ]
Devereaux, P. J. [1 ]
Montori, Victor M. [9 ]
Freyschuss, Bo [10 ]
Vist, Gunn [3 ]
Jaeschke, Roman [2 ]
Williams, John W., Jr. [11 ]
Murad, Mohammad Hassan [9 ]
Sinclair, David [12 ]
Falck-Ytter, Yngve [13 ]
Meerpohl, Joerg [14 ,15 ]
Whittington, Craig [16 ]
Thorlund, Kristian [1 ]
Andrews, Jeff [17 ]
Schuenemann, Holger J. [1 ,2 ]
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[3] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway
[4] Univ Basel Hosp, Acad Swiss Insurance Med, CH-4031 Basel, Switzerland
[5] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland
[6] Univ Autonoma Barcelona, Iberoamer Cochrane Ctr, Serv Epidemiol Clin & Salud Publ, Barcelona 08041, Spain
[7] Univ Autonoma Barcelona, Hosp St Pau, CIBERESP, Barcelona 08041, Spain
[8] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[9] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN USA
[10] Karolinska Univ Hosp, Dept Med, Karolinska Inst M54, S-14186 Huddinge, Sweden
[11] Duke Univ, Med Ctr, Durham VA Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA
[12] Univ Liverpool, Liverpool Sch Trop Med, Effect Hlth Care Res Consortium, Liverpool L3 5QA, Merseyside, England
[13] Case Western Reserve Univ, Div Gastroenterol, Dept Med, Case & VA Med Ctr, Cleveland, OH 44106 USA
[14] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, D-79104 Freiburg, Germany
[15] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, D-79106 Freiburg, Germany
[16] UCL, Res Dept Clin Educ & Hlth Psychol, Ctr Outcomes Res & Effectiveness, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England
[17] Vanderbilt Univ, Vanderbilt Evidence Based Practice Ctr, Nashville, TN USA
关键词
GRADE; Quality of evidence; Confidence in estimates; Imprecision; Optimal information size; Confidence intervals; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIALS; PERIOPERATIVE BETA-BLOCKERS; NONCARDIAC SURGERY; INTRAVENOUS MAGNESIUM; METAANALYSIS; MORTALITY; PREVENTION; ASPIRIN; ALBUMIN;
D O I
10.1016/j.jclinepi.2011.01.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
GRADE suggests that examination of 95% confidence intervals (CIs) provides the optimal primary approach to decisions regarding imprecision. For practice guidelines, rating down the quality of evidence (i.e., confidence in estimates of effect) is required if clinical action would differ if the upper versus the lower boundary of the CI represented the truth. An exception to this rule occurs when an effect is large, and consideration of CIs alone suggests a robust effect, but the total sample size is not large and the number of events is small. Under these circumstances, one should consider rating down for imprecision. To inform this decision, one can calculate the number of patients required for an adequately powered individual trial (termed the "optimal information size" [OIS]). For continuous variables, we suggest a similar process, initially considering the upper and lower limits of the CI, and subsequently calculating an OIS. Systematic reviews require a somewhat different approach. If the 95% CI excludes a relative risk (RR) of 1.0, and the total number of events or patients exceeds the OIS criterion, precision is adequate. If the 95% CI includes appreciable benefit or harm (we suggest an RR of under 0.75 or over 1.25 as a rough guide) rating down for imprecision may be appropriate even if OIS criteria are met. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1283 / 1293
页数:11
相关论文
共 26 条
[1]
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials [J].
Abuissa, H ;
Jones, PG ;
Marso, SP ;
O'Keefe, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) :821-826
[2]
Meta-analysis of flavonoids for the treatment of haemorrhoids [J].
Alonso-Coello, P. ;
Zhou, Q. ;
Martinez-Zapata, M. J. ;
Mills, E. ;
Heels-Ansdell, D. ;
Johanson, J. F. ;
Guyatt, G. .
BRITISH JOURNAL OF SURGERY, 2006, 93 (08) :909-920
[3]
[Anonymous], LANCET
[4]
[Anonymous], 1998, BMJ, V317, P235
[5]
[Anonymous], CONTROL CLIN TRIALS
[6]
[Anonymous], 1995, LANCET, V345, P669
[7]
Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis [J].
Bangalore, Sripal ;
Wetterslev, Jorn ;
Pranesh, Shruthi ;
Sawhney, Sabrina ;
Gluud, Christian ;
Messerli, Franz H. .
LANCET, 2008, 372 (9654) :1962-1976
[8]
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis [J].
Bassler, Dirk ;
Briel, Matthias ;
Montori, Victor M. ;
Lane, Melanie ;
Glasziou, Paul ;
Zhou, Qi ;
Heels-Ansdell, Diane ;
Walter, Stephen D. ;
Guyatt, Gordon H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (12) :1180-1187
[9]
Bosch J, 2006, NEW ENGL J MED, V355, P1551
[10]
Probiotics for induction of remission in Crohn's disease [J].
Butterworth, Andrew D. ;
Thomas, Adrian G. ;
Akobeng, Anthony Kwaku .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03)